← Back to patent-cliff list
Maritupirdine Hydrochloride
Tier C — Watch / tradeMaritupirdine Hydrochloride
Avineuro
Originator
2023
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT6
Brand：АВИАНДР
Indications (approved)：Anxiety disorder
Regional status
US
-
EU
Approved
2023-05-31
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Maritupirdine Hydrochloride?
Approved indications include: Anxiety disorder.
When does the Maritupirdine Hydrochloride patent expire?
No public expiry year is available for Maritupirdine Hydrochloride yet; this page updates once verified.
How do I get a quote for Maritupirdine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27